BPC-157 directly addresses this limitation by stimulating new blood vessel growth into tendon tissue
doi:10.5530/ijmedph.2024.2.115 2026 The Author(s)
The main differences between Sermorelin and BPC 157 are defined by their mechanisms of action
In a rat alkali-burn wound model, BPC-157 was associated with ERK1/2 activation and faster wound closure, along with increased proliferation and migration of endothelial cells in a parallel in vitro assay
These signs and symptoms can include brain dysfunction, trouble eating, muscle weakness, enlarged liver, tiredness, confusion, low blood sugar, and heart problems
Small and large fiber neuropathy in those with type 1 and type 2 diabetes: a 5-year follow-up study